226 related articles for article (PubMed ID: 6255072)
1. A non-virion surface antigen on Moloney sarcoma virus-transformed non-producer and producer cells.
Hunsmann G; Weiland E; Mussgay M; Schneider J
J Gen Virol; 1980 Aug; 49(2):375-84. PubMed ID: 6255072
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody detects a common surface antigen on two independently established murine Moloney sarcoma virus non-producer transformants.
Weiland E; Thiel HJ
J Gen Virol; 1985 Sep; 66 ( Pt 9)():1863-72. PubMed ID: 2993478
[TBL] [Abstract][Full Text] [Related]
3. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
BasombrÃo MA; Mayer AM; Pasqualini CD
Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
[TBL] [Abstract][Full Text] [Related]
4. Simian virus 40 and Moloney-murine sarcoma virus infection of bona fide mouse epithelium.
Anderson LW; Smith HS
J Gen Virol; 1980 Aug; 49(2):443-6. PubMed ID: 6255079
[TBL] [Abstract][Full Text] [Related]
5. Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells.
Weiland F; Weiland E; Mussgay M
Br J Cancer; 1979 Dec; 40(6):932-42. PubMed ID: 230854
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
7. Two levels of restriction by mouse or cat cells of murine sarcoma virus coated by endogenous xenotropic oncornavirus.
Fischinger PJ; Nomura S; Blevins CS; Bolognesi DP
J Gen Virol; 1975 Oct; 29(1):51-62. PubMed ID: 171336
[TBL] [Abstract][Full Text] [Related]
8. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
9. Antiserum to murine leukemia virus recognizes novel cell surface molecules associated with growth control and transformation.
Rieber M; Rieber M; Alonso M
Int J Cancer; 1979 Apr; 23(4):547-54. PubMed ID: 86526
[TBL] [Abstract][Full Text] [Related]
10. Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.
Weiland E; Mussgay M
Arch Virol; 1980; 66(1):1-10. PubMed ID: 7436738
[TBL] [Abstract][Full Text] [Related]
11. possible role of a retrovirus in the expression of tumor-specific antigens of the Meth A sarcoma.
DeLeo AB; Chang KS; Wivel NA; Appella E; Old LJ; Law LW
Int J Cancer; 1982 Jun; 29(6):687-93. PubMed ID: 7107069
[TBL] [Abstract][Full Text] [Related]
12. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). II. Detection of cell-surface antigens by indirect membrane immunofluorescence.
Jones DB; Moore M
Br J Cancer; 1974 Feb; 29(2):158-67. PubMed ID: 4133783
[TBL] [Abstract][Full Text] [Related]
13. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
Jones DB; Moore M
Br J Cancer; 1974 Jan; 29(1):21-30. PubMed ID: 4820943
[TBL] [Abstract][Full Text] [Related]
14. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
Levy JP; Leclerc JC
Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
[No Abstract] [Full Text] [Related]
15. The induction of immunoblastic T cell sarcomas by virus-transformed prothymocytes.
Reinisch CL; Kurtz SE; Morris EA; Lampert A
Am J Pathol; 1980 Nov; 101(2):265-82. PubMed ID: 6254363
[TBL] [Abstract][Full Text] [Related]
16. Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells.
Stephenson JR; Aaronson SA
J Exp Med; 1972 Mar; 135(3):503-15. PubMed ID: 4550769
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity to moloney sarcoma virus in mice. I. Analysis of antigens responsible for lymphocyte stimulation in regressor mice.
Knight RA; Gorczynski RM
Int J Cancer; 1975 Jan; 15(1):48-58. PubMed ID: 47841
[TBL] [Abstract][Full Text] [Related]
18. Transformed cell lines derived from progressor Sarcoma virus (Moloney) induced tumors. I. Differences in pathogenicity between C type viruses from producer and helper virus infected nonproducer cells.
Weiland E; Mussgay M
Arch Virol; 1982; 71(4):343-7. PubMed ID: 7092573
[No Abstract] [Full Text] [Related]
19. Ribonucleic acid components of murine sarcoma and leukemia viruses.
Maisel J; Klement V; Lai MM; Ostertag W; Duesberg P
Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3536-40. PubMed ID: 4357879
[TBL] [Abstract][Full Text] [Related]
20. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
